Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05550727 · ClinicalTrials.gov registry record · NA

The PorchLight Project

A NA study of Alzheimer Disease and Dementia, sponsored by University of Minnesota.

Active
Registry status
NA
Development phase
342
Enrollment target
1
Study location

NCT05550727: Active NA study of Alzheimer Disease and Dementia, sponsored by University of Minnesota.

NCT05550727 is a NA study of Alzheimer Disease and Dementia that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 342 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05550727, a NA study of Alzheimer Disease and Dementia, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
342 participants
Enrollment target
1
Study location

Study Summary

The proposed project is a fully embedded pragmatic trial (R01), following an R61 pilot collaboration with Lutheran Social Service of Minnesota (LSS-MN). For this project: a) the training program for Senior Companions that was developed in the R61 Phase will now be delivered as part of a routine onboarding process provided by LSS-MN to all senior support volunteers in half of their program regions across Minnesota; LSS-MN will offer the PorchLight Project program to all regions and volunteers in the state during the final months of the proposed NIA project, consistent with quality improvement approaches; and b) LSS-MN will administer regular surveys to volunteers, clients, and caregivers as part of ongoing tracking and quality improvement efforts. The University of Minnesota investigators will not collect data nor administer training, as these activities will be fully integrated into the workflow of LSS-MN. \[Note: Since it was learned that caregivers receiving services/affiliated with LSS-MN programming who receive surveys are for the most part not providing care to LSS-MN clients, as of fall 2024, UMN will no longer request and analyze data on LSS-MN caregivers.\] UNIVERSITY OF MINNESOTA INVOLVEMENT: The University of Minnesota and collaborating investigators outside of LSS-MN will only 1) assist in survey item selection, 2) randomize the LSS-MN regions for the initial phases of the real-world trial for evaluation purposes, 3) analyze the de-identified data shared by LSS-MN, and 4) disseminate the project results in scientific, practice, and policy outlets/contexts.

Primary Outcome

6-items assess the preparedness to provide visiting services for clients with a variety of conditions, including memory loss. This measure was designed for LSS-MN to determine the proportion of volunteers who indicate their level of preparedness.

Interventions

  • OTHER PorchLight

Study Locations (1)

Minnesota

  • University of Minnesota (with Lutheran Social Service of Minnesota) - Minneapolis

Trial Details

FieldValue
Enrollment Target 342 participants
Start Date 2022-09-23
Est. Completion 2026-10-30
Phase NA
University of Minnesota

966 total trials

What the registry record for NCT05550727 still lists

NCT05550727 is an interventional study that assigns participants to a tested intervention. The registered 342 participants enrollment target is mid-sized for trials with a published cap, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (88% lower).

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which PorchLight is the first listed.

NCT05550727 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05550727 about?

NCT05550727 is a clinical study titled "The PorchLight Project". The proposed project is a fully embedded pragmatic trial (R01), following an R61 pilot collaboration with Lutheran Social Service of Minnesota (LSS-MN). For this project: a) the training program for Senior Companions that was developed in the R61 Phase will now be delivered as part of a routine onb...

What is the current status of trial NCT05550727?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 342 participants. The study started on 2022-09-23. Estimated completion is 2026-10-30.

What conditions does trial NCT05550727 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia, Memory Loss.

What interventions are being tested in trial NCT05550727?

The interventions under investigation include: PorchLight (OTHER).

Who is sponsoring clinical trial NCT05550727?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05550727 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05550727's enrollment target sits among peer trials

342 77th of 306 higher than 230 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05283850 · 342 participants · Phase 2

    Surviving PEA in Roanoke (SPEAR) Study

  • NCT05714085 · 342 participants · Phase 2

    Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • NCT06188702 · 342 participants · Phase 1

    S095035 as a Single Agent and in Combination in Adult Participants With Advanced or Metastatic Solid Tumors With Deletion of MTAP

  • NCT06544941 · 342 participants · NA

    Improving Maternal Sleep and Mental Health

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05550727, the US trial registry maintained by the National Library of Medicine. NCT05550727 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.